Stoke Therapeutics (NASDAQ:STOK) Insider Sells 1,051 Shares of Stock
MarketBeat
Stoke Therapeutics (NASDAQ:STOK) insider Barry Ticho sold 1,051 shares of the company's stock for $27,494.16 on October 1st, reducing his stake by 5.23% to 19,059 shares. The sale was executed under a pre-arranged Rule 10b5-1 plan. Despite the insider selling and recent stock price declines, analysts maintain a "Moderate Buy" rating with a consensus price target of $44.25, and institutional investors have been increasing their positions.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.